Related Experiment Video
Updated: Feb 6, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors
Margaret B Pulsifer1, Haley Duncanson1, Julie Grieco1
1Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Harvard University, Boston, Massachusetts.
Insights
Proton beam radiation therapy (PRT) for pediatric brain tumors showed stable adaptive skills. Younger patients receiving craniospinal irradiation (CSI) experienced significant IQ decline, while others showed minimal changes.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Neuroscience
Background:
- Radiation therapy is crucial for pediatric brain tumors but can cause long-term side effects.
- Proton beam radiation therapy (PRT) offers precise targeting, potentially reducing sequelae.
- Understanding the neurocognitive and adaptive outcomes of PRT is essential for long-term patient care.
Purpose of the Study:
- To prospectively evaluate the cognitive and adaptive functioning of pediatric and young adult patients treated with PRT.
- To identify specific patient groups or treatment parameters associated with differential outcomes.
Main Methods:
- 155 patients treated with PRT were assessed at baseline and follow-up (mean 3.6 years).
- Assessments included age-appropriate measures of intelligence quotient (IQ) and adaptive functioning.
- Patients were stratified by age at baseline (<6 years vs. ≥6 years) and PRT field (craniospinal irradiation [CSI] vs. focal irradiation).
Main Results:
- Mean IQ and adaptive functioning scores remained in the average range at baseline and follow-up.
- Overall mean IQ showed a slight decline (105.4 to 102.5, P=.005).
- Younger patients (<6 years) receiving CSI demonstrated a significant decline in IQ, processing speed, and working memory. Adaptive skills were stable across all groups.
Conclusions:
- PRT resulted in stable adaptive functioning in pediatric brain tumor patients.
- Younger patients treated with CSI are particularly vulnerable to IQ decline.
- Focal PRT did not significantly impact IQ in younger patients, and older patients showed no significant changes, suggesting treatment modality and age are critical factors.
Purpose:
Radiation therapy is integral in treatment of pediatric brain tumors, but it is associated with negative long-term sequelae. Proton beam radiation therapy (PRT), which enables better focusing of radiation on tumors, may entail fewer sequelae. This prospective study examined cognitive and adaptive functioning in children and young adults treated with PRT.
Methods And Materials:
A total of 155 patients were assessed using age-appropriate measures for cognitive and adaptive functioning at start of or during PRT (baseline) and at follow-up. Mean age at baseline was 8.9 years; mean follow-up interval was 3.6 years. Diagnoses included medulloblastoma, craniopharyngioma, ependymoma, glial tumors, germ cell tumors, and others. The sample was divided by age at baseline (<6 years [N = 57, or 37%] and ≥6 years [N = 98, or 63%]) and by PRT field (craniospinal irradiation [CSI; 39%] and focal irradiation [61%]).
Results:
Scores for mean intelligence quotient (IQ) and adaptive functioning skills were in the average range at baseline and follow-up. Overall, mean IQ scores declined from 105.4 to 102.5 (P = .005); however, only the younger CSI group showed significant decline. Patients receiving CSI, regardless of age, appeared particularly vulnerable in IQ, processing speed, and working memory. Adaptive skills were stable across the 4 age-by-treatment field groups.
Conclusions:
At a mean of 3.6 years after PRT, IQ declined slightly for the group, largely because of significant IQ decline in younger patients treated with CSI. No significant change was seen in patients <6 years treated with focal PRT or in older patients. Adaptive skills remained stable across age and treatment type.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Biological Effects of Radiation
Cognitive Dissonance

